慢性肾脏病中的亚临床认知障碍与衰弱及生活质量降低相关
该前瞻性研究纳入62例非透析慢性肾脏病3-5期患者,通过五项心理测量测试定义亚临床尿毒症脑病1(SUE1:一项测试异常)和2(SUE2:两项及以上测试异常)。认知障碍高发(SUE1 60%、SUE2 42%),且与跌倒风险升高、肌力下降、衰弱及健康相关生活质量降低相关。
要点
- 非透析慢性肾脏病3-5期患者中认知障碍高发,SUE1占60%、SUE2占42%。
- 即使轻度认知障碍也与移动能力、肌力和健康相关生活质量下降及衰弱增加相关。
- 认知障碍患者跌倒风险更高,SUE1组异常串联步态测试50% vs 16%。
核心结论
- 认知障碍在非透析慢性肾脏病患者中高发,即使轻度认知障碍也与移动能力、肌力和健康相关生活质量下降及衰弱增加相关。
研究设计与样本
- 前瞻性纳入非透析慢性肾脏病3-5期患者,排除其他认知障碍、明显尿毒症脑病征象、严重感染和低钠血症者。
- 共纳入62例患者,中位年龄66岁(四分位距57-75),男性55%。
- CKD分期分布:3期48%、4期32%、5期19%。
- 所有患者接受五项心理测量测试,并评估移动能力、肌力、衰弱和健康相关生活质量。
- 基于心理测量测试异常结果数量定义两种认知障碍:SUE1(一项测试异常)和SUE2(两项及以上测试异常)。
主要发现
- 认知障碍高发:SUE1占60%,SUE2占42%。
- 跌倒风险升高(异常串联步态测试):SUE1组50% vs 非SUE1组16%,P=.023;SUE2组69% vs 非SUE2组15%,P=.001。
- 肌力下降(SUE2异常组):39% vs 7%,P=.008。
- 衰弱:SUE1组59% vs 28%,P=.038;SUE2组67% vs 33%,P=.028。
- 认知障碍与健康相关生活质量降低相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cognitive impairment (CI) in chronic kidney disease (CKD) is highly prevalent and is associated with multiple limitations to patients as well as a higher mortality, more days of hospitalisation and a lower quality of life. Frailty in CKD is associated with adverse health outcomes and is also highly prevalent. The aim of our study was to determine the prevalence and characteristics of CI and relate the findings to frailty, mobility, muscle strength and health-related quality of life (HRQOL). METHODS: Non-dialysis patients with CKD stages 3-5 were prospectively evaluated for inclusion. Excluded were patients with other cognitive disorders, signs of overt uraemic encephalopathy, severe infection and hyponatraemia. All patients underwent psychometric testing (five different tests): assessments of mobility, strength and frailty and an evaluation of HRQOL. Based on the number of pathological psychometric test results, we established two different definitions of CI: subclinical uraemic encephalopathy 1 (SUE1: one pathological test) and subclinical uraemic encephalopathy 2 (SUE2: two or more pathological test results). RESULTS: Sixty-two patients were included [median age 66 years (interquartile range 57-75), male 55%]. Most patients had CKD stage 3 (48%; stage 4: 32%; stage 5: 19%). CI was highly prevalent (SUE1: 60%; SUE2: 42%) and associated with a higher risk of falls (pathological tandem gait test; SUE1: 50% versus 16%, P = .023; SUE2: 69% versus 15%, P = .001), lower muscle strength (SUE2-pathological: 39% versus 7%, P = .008), frailty (SUE1: 59% versus 28%, P = .038; SUE2: 67% versus 33%, P = .028) and HRQOL. CONCLUSION: CI is highly prevalent in non-dialysis CKD patients. Even mild CI is associated with decreased mobility, muscle strength and HRQOL and increased frailty.
引用
- Greinert R, Greinert D, Eger AL, et al. Subclinical cognitive impairment in chronic kidney disease is associated with frailty and reduced quality of life. Nephrol Dial Transplant. 2023. PMID: 36323454. doi:10.1093/ndt/gfac303
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。